Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.
B J van Vlijmen, … , M H Hofker, L M Havekes
B J van Vlijmen, … , M H Hofker, L M Havekes
Published April 1, 1994
Citation Information: J Clin Invest. 1994;93(4):1403-1410. https://doi.org/10.1172/JCI117117.
View: Text | PDF
Research Article

Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

  • Text
  • PDF
Abstract

Apolipoprotein E3-Leiden (APOE*3-Leiden) transgenic mice have been used to study the effect of different cholesterol-containing diets on the remnant lipoprotein levels and composition and on the possible concurrent development of atherosclerotic plaques. On high fat/cholesterol (HFC) diet, the high expressing lines 2 and 181 developed severe hypercholesterolemia (up to 40 and 60 mmol/liter, respectively), whereas triglyceride levels remained almost normal when compared with regular mouse diet. The addition of cholate increased the hypercholesterolemic effect of this diet. In lines 2 and 181, serum levels of apo E3-Leiden also increased dramatically upon cholesterol feeding (up to 107 and 300 mg/dl, respectively). In these high expressing APOE*3-Leiden transgenic mice, the increase in both serum cholesterol and apo E3-Leiden occurred mainly in the VLDL/LDL-sized fractions, whereas a considerable increase in large, apo E-rich HDL particles also occurred. In contrast to the high expressing lines, the low expressing line 195 reacted only mildly upon HFC diet. On HFC diets, the high expresser APOE*3-Leiden mice developed atherosclerotic lesions in the aortic arch, the descending aorta, and the carotid arteries, varying from fatty streaks containing foam cells to severe atherosclerotic plaques containing cholesterol crystals, fibrosis, and necrotic calcified tissue. Quantitative evaluation revealed that the atherogenesis is positively correlated with the serum level of cholesterol-rich VLDL/LDL particles. In conclusion, with APOE*3-Leiden transgenic mice, factors can be studied that influence the metabolism of remnant VLDL and the development of atherosclerosis.

Authors

B J van Vlijmen, A M van den Maagdenberg, M J Gijbels, H van der Boom, H HogenEsch, R R Frants, M H Hofker, L M Havekes

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1990 Total
Citations: 1 1 1 3 4 4 8 4 6 11 2 17 6 12 6 7 8 10 5 7 9 7 6 3 8 9 7 7 5 10 5 3 1 203
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (203)

Title and authors Publication Year
Silencing of the von Willebrand factor gene in proatherothrombotic APOE∗3-Leiden.CETP transgenic mice
Jongejan YK, Dirven RJ, Schrader Echeverri E, de Jong AJ, Pronk AC, Kooijman S, Rensen PC, Dahlman JE, Eikenboom JC, van Vlijmen BJ
Research and Practice in Thrombosis and Haemostasis 2025
Development of a Microminipig Model of Atherosclerosis for the Evaluation of a HMGCR Inhibitor.
Yamada T, Kawaguchi H, Matsuoka A, Akioka K, Miura N, Izumi H, Tanimoto A
In vivo (Athens, Greece) 2024
Nanomedicine for Diagnosis and Treatment of Atherosclerosis.
Cheng J, Huang H, Chen Y, Wu R
2023
Atherosclerosis: Methods and Protocols
D Ramji
2022
Characterization of Retinal Drusen in Subjects at High Genetic Risk of Developing Sporadic Alzheimer's Disease: An Exploratory Analysis.
López-Cuenca I, Salobrar-García E, Gil-Salgado I, Sánchez-Puebla L, Elvira-Hurtado L, Fernández-Albarral JA, Ramírez-Toraño F, Barabash A, de Frutos-Lucas J, Salazar JJ, Ramírez JM, Ramírez AI, de Hoz R
Journal of Personalized Medicine 2022
Role of thermogenic adipose tissue in lipid metabolism and atherosclerotic cardiovascular disease: lessons from studies in mice and humans
Ying Z, Tramper N, Zhou E, Boon MR, Rensen PC, Kooijman S
Cardiovascular Research 2022
Vascular Calcification in Rodent Models—Keeping Track with an Extented Method Assortment
J Herrmann, MR Gummi, M Xia, M van der Giet, M Tölle, M Schuchardt
Biology : open access journal 2021
P300/CBP Associated Factor (PCAF) Deficiency Enhances Diet-Induced Atherosclerosis in ApoE3*Leiden Mice via Systemic Inhibition of Regulatory T Cells
A de Jong, RC de Jong, EA Peters, R Arens, JW Jukema, MR de Vries, PH Quax
Frontiers in Cardiovascular Medicine 2021
The effect of cold exposure on serum cholesterol is dependent upon ApoE
F He, W Su, R Wu, H Li, L Lou, A Wu, L Xie, Y Du, S Wu
Journal of Thermal Biology 2021
Atherothrombosis model by silencing of protein C in APOE*3-Leiden.CETP transgenic mice
YK Jongejan, JC Eikenboom, MJ Gijbels, JF Berbée, BJ van Vlijmen
Journal of Thrombosis and Thrombolysis 2021
Research Models for Studying Vascular Calcification
J Herrmann, M Babic, M Tölle, M van der Giet, M Schuchardt
International journal of molecular sciences 2020
Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models
D Basu, KE Bornfeldt
Frontiers in Endocrinology 2020
Mouse models of atherosclerosis and their suitability for the study of myocardial infarction
P Golforoush, DM Yellon, SM Davidson
Basic Research in Cardiology 2020
Small rodent models of atherosclerosis
Y Zhao, H Qu, Y Wang, W Xiao, Y Zhang, D Shi
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2020
Hypercholesterolemia affects cardiac function, infarct size and inflammation in APOE*3-Leiden mice following myocardial ischemia-reperfusion injury
NJ Pluijmert, MC den Haan, VL van Zuylen, P Steendijk, HC de Boer, AJ van Zonneveld, WE Fibbe, MJ Schalij, PH Quax, DE Atsma, V Lionetti
PloS one 2019
Effects of Pharmacological Thermogenic Adipocyte Activation on Metabolism and Atherosclerotic Plaque Regression
A Worthmann, C Schlein, J Berbée, P Rensen, J Heeren, A Bartelt
Nutrients 2019
Colesevelam enhances the beneficial effects of brown fat activation on hyperlipidaemia and atherosclerosis development
E Zhou, G Hoeke, Z Li, AC Eibergen, AW Schonk, M Koehorst, R Boverhof, R Havinga, F Kuipers, T Coskun, MR Boon, AK Groen, PC Rensen, JF Berbée, Y Wang
Cardiovascular Research 2019
Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease
AD Marais
Pathology 2019
CKIP-1 limits foam cell formation and inhibits atherosclerosis by promoting degradation of Oct-1 by REGγ
J Fan, L Liu, Q Liu, Y Cui, B Yao, M Zhang, Y Gao, Y Fu, H Dai, J Pan, Y Qiu, CH Liu, F He, Y Wang, L Zhang
Nature Communications 2019
Local intravascular delivery of low-density-lipoprotein cholesterol corresponds with increased intimal thickening in a healthy porcine coronary model. A prelude to development of a model of atherosclerosis
PP Buszman, B Orlik, KP Milewski, T Roleder, M Jelonek, F Polczyk, FD Kolodgie, M Jankowski, R Virmani, PE Buszman
POSTEP KARDIOL INTER 2019
The APOE ∗ 3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis
MG Pouwer, SE Heinonen, M Behrendt, AC Andréasson, A van Koppen, AL Menke, EJ Pieterman, AM van den Hoek, JW Jukema, B Leighton, AC Jönsson-Rylander, HM Princen
Journal of Diabetes Research 2019
Modelling of atherosclerosis in genetically modified animals
Natalia V Mushenkova, Volha I Summerhill, Yulia Yu Silaeva, Alexey V Deykin, Alexander N Orekhov
American journal of translational research 2019
Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions
Elizabeth D Crane, Ali A. Al-Hashimi, Jack Chen, Edward G. Lynn, Kevin D Won, Šárka Lhotak, Magda Naeim, Khrystyna Platko, Paul Lebeau, Jae Hyun Byun, Bobby Shayegan, Katey Rayner, Joan Krepinsky, Serena Marchiò, Renata Pasqualini, Wadih Arap, Richard C. Austin
JCI Insight 2018
RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr−/− mice
M Bijnen, N Beelen, S Wetzels, J van de Gaar, M Vroomen, E Wijnands, JL Scheijen, MP van de Waarenburg, MJ Gijbels, JP Cleutjens, EA Biessen, CD Stehouwer, CG Schalkwijk, K Wouters
Scientific Reports 2018
Understanding the Impact of Dietary Cholesterol on Chronic Metabolic Diseases through Studies in Rodent Models
Á Vinué, A Herrero-Cervera, H González-Navarro
Nutrients 2018
Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects
M Lupo, N Ferri
Journal of Cardiovascular Development and Disease 2018
Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis
Y Luo, H Duan, Y Qian, L Feng, Z Wu, F Wang, J Feng, D Yang, Z Qin, X Yan
Cell Research 2017
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
FE Dewey, V Gusarova, RL Dunbar, C ODushlaine, C Schurmann, O Gottesman, S McCarthy, CV Hout, S Bruse, HM Dansky, JB Leader, MF Murray, MD Ritchie, HL Kirchner, L Habegger, A Lopez, J Penn, A Zhao, W Shao, N Stahl, AJ Murphy, S Hamon, A Bouzelmat, R Zhang, B Shumel, R Pordy, D Gipe, GA Herman, WH Sheu, IT Lee, KW Liang, X Guo, JI Rotter, YD Chen, WE Kraus, SH Shah, S Damrauer, A Small, DJ Rader, AB Wulff, BG Nordestgaard, A Tybjærg-Hansen, AM van den Hoek, HM Princen, DH Ledbetter, DJ Carey, JD Overton, JG Reid, WJ Sasiela, P Banerjee, AR Shuldiner, IB Borecki, TM Teslovich, GD Yancopoulos, SJ Mellis, J Gromada, A Baras
New England Journal of Medicine 2017
The P2Y 2 nucleotide receptor is an inhibitor of vascular calcification
S Qian, JN Regan, MT Shelton, A Hoggatt, KS Mohammad, PB Herring, CI Seye
Atherosclerosis 2017
Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development
PP Khedoe, S Kleijn, AM van Oeveren-Rietdijk, JJ Plomp, HC de Boer, M Pel, PC Rensen, JF Berbée, PS Hiemstra, AÖ Yildirim
PloS one 2017
Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease
GH Norris, CN Blesso
Nutrition Reviews 2017
Experimental Models of Hyperlipoproteinemia and Atherosclerosis
R Poledne, L Jurčíková-Novotná
Physiological research / Academia Scientiarum Bohemoslovaca 2017
Translational atherosclerosis research: From experimental models to coronary artery disease in humans
CA Gleissner
Atherosclerosis 2016
Deletion of P2Y2 receptor reveals a role for lymphotoxin-α in fatty streak formation
S Qian, A Hoggatt, YL Jones-Hall, CF Ware, P Herring, CI Seye
Vascular Pharmacology 2016
Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models
S Gargiulo, M Gramanzini, M Mancini
International journal of molecular sciences 2016
Endothelial Jag1-RBPJ signalling promotes inflammatory leucocyte recruitment and atherosclerosis
M Nus, B Martínez-Poveda, D MacGrogan, R Chevre, GD Amato, M Sbroggio, C Rodríguez, J Martínez-González, V Andrés, A Hidalgo, JL de la Pompa
Cardiovascular Research 2016
Early intake of long-chain polyunsaturated fatty acids preserves brain structure and function in diet-induced obesity
IA Arnoldussen, V Zerbi, M Wiesmann, RH Noordman, S Bolijn, MP Mutsaers, PJ Dederen, R Kleemann, T Kooistra, EA van Tol, G Gross, MH Schoemaker, A Heerschap, PY Wielinga, AJ Kiliaan
The Journal of Nutritional Biochemistry 2016
Employing biomarkers of healthy ageing for leveraging genetic studies into human longevity
J Deelen, EB van Akker, S Trompet, D Heemst, SP Mooijaart, PE Slagboom, M Beekman
Experimental Gerontology 2016
L’attivazione del grasso bruno riduce l’ipercolesterolemia e protegge dallo sviluppo dell’aterosclerosi
A Fabbri
L'Endocrinologo 2016
Classification for Longevity Potential: The Use of Novel Biomarkers
M Beekman, HW Uh, D Heemst, M Wuhrer, LR Ruhaak, V Gonzalez-Covarrubias, T Hankemeier, JJ Houwing-Duistermaat, PE Slagboom
Frontiers in public health 2016
Deletion of P2Y 2 receptor reveals a role for lymphotoxin-α in fatty streak formation
S Qian, A Hoggatt, YL Jones-Hall, CF Ware, P Herring, CI Seye
Vascular Pharmacology 2016
Insulin decreases atherosclerotic plaque burden and increases plaque stability via nitric oxide synthase in apolipoprotein E-null mice
Y Mori, S Chiang, MP Bendeck, A Giacca
American journal of physiology. Endocrinology and metabolism 2016
Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease
PP Khedoe, PC Rensen, JF Berbée, PS Hiemstra
American journal of physiology. Lung cellular and molecular physiology 2016
Methods in Molecular Biology
GS Getz, CA Reardon
Methods in molecular biology (Clifton, N.J.) 2015
Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development
JF Berbée, MR Boon, PP Khedoe, A Bartelt, C Schlein, A Worthmann, S Kooijman, G Hoeke, IM Mol, C John, C Jung, N Vazirpanah, LP Brouwers, PL Gordts, JD Esko, PS Hiemstra, LM Havekes, L Scheja, J Heeren, PC Rensen
Nature Communications 2015
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
High Density Lipoproteins
A von Eckardstein, D Kardassis
2014
Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin
S Kuhnast, JW van der Hoorn, EJ Pieterman, AM van Hoek, WJ Sasiela, V Gusarova, A Peyman, HL Schafer, U Schwahn, JW Jukema, HM Princen
Journal of lipid research 2014
Most appropriate animal models to study the efficacy of statins: a systematic review
V Pecoraro, L Moja, L Dall'Olmo, G Cappellini, S Garattini
European Journal of Clinical Investigation 2014
New prospect of bile acid sequestrants as a novel therapy for metabolic disorders — research strategy utilizing clinical data
K Sugimoto
Folia Pharmacologica Japonica 2014
Mouse models of atherosclerosis: explaining critical roles of lipid metabolism and inflammation
R Mukhopadhyay
Journal of Applied Genetics 2013
Animal Models for the Study of Human Disease
HA Lawson
Animal Models for the Study of Human Disease 2013
Colestilan decreases weight gain by enhanced NEFA incorporation in biliary lipids and fecal lipid excretion
K Sugimoto-Kawabata, H Shimada, K Sakai, K Suzuki, T Kelder, EJ Pieterman, LH Cohen, LM Havekes, HM Princen, AM van Hoek
Journal of lipid research 2013
Modelos experimentales de aterosclerosis
CG Santos-Gallego, JJ Badimon, B Ibáñez
Revista Española de Cardiología Suplementos 2013
The Effect of PPE-Induced Emphysema and Chronic LPS-Induced Pulmonary Inflammation on Atherosclerosis Development in APOE*3-LEIDEN Mice
PP Khedoe, MC Wong, GT Wagenaar, JJ Plomp, M Eck, LM Havekes, PC Rensen, PS Hiemstra, JF Berbée, C Taube
PloS one 2013
Combined Analysis of Pharmacokinetic and Efficacy Data of Preclinical Studies with Statins Markedly Improves Translation of Drug Efficacy to Human Trials
E van de Steeg, R Kleemann, HT Jansen, W van Duyvenvoorde, EH Offerman, HM Wortelboer, J DeGroot
The Journal of pharmacology and experimental therapeutics 2013
Chronic Intermittent Hypoxia Is an Independent Causative Factor For Atherosclerosis In The Mice
Guoqiang Fang, Dongmei Song, Xiaobing Ye, Sun-zhong Mao, Gang Liu, Shu Fang Liu
Biochimica et Biophysica Acta 2012
Animal Models of Atherosclerosis
GS Getz, CA Reardon
Arteriosclerosis, thrombosis, and vascular biology 2012
GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice
ET Parlevliet, Y Wang, JJ Geerling, JP der Elst, K Picha, K O'Neil, V Stojanovic-Susulic, T Ort, LM Havekes, JA Romijn, H Pijl, PC Rensen
PloS one 2012
Current Protocols in Immunology
E Maganto-Garcia, M Tarrio, AH Lichtman
Current Protocols in Immunology 2012
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Dietary modification of metabolic pathways via nuclear hormone receptors: NUCLEAR HORMONE RECEPTORS AND NUTRITION
G Caiozzi, BS Wong, ML Ricketts
Cell Biochemistry and Function 2012
Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp. shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet
A Oksaharju, T Kooistra, R Kleemann, W Duyvenvoorde, M Miettinen, J Lappalainen, KA Lindstedt, PT Kovanen, R Korpela, RA Kekkonen
British Journal of Nutrition 2012
Chronic intermittent hypoxia exposure induces atherosclerosis in ApoE knockout mice: role of NF-κB p50
G Fang, D Song, X Ye, S Mao, G Liu, SF Liu
The American Journal of Pathology 2012
GLP-1 Receptor Activation Inhibits VLDL Production and Reverses Hepatic Steatosis by Decreasing Hepatic Lipogenesis in High-Fat-Fed APOE*3-Leiden Mice
ET Parlevliet, Y Wang, JJ Geerling, JP der Elst, K Picha, K O'Neil, V Stojanovic-Susulic, T Ort, LM Havekes, JA Romijn, H Pijl, PC Rensen, E Lutgens
PloS one 2012
Identification of prognostic and diagnostic biomarkers of glucose intolerance in ApoE3Leiden mice
S Wopereis, M Radonjic, C Rubingh, M Erk, A Smilde, W Duyvenvoorde, N Cnubben, T Kooistra, B Ommen, R Kleemann
Physiological genomics 2012
Lipidomics Reveals Multiple Pathway Effects of a Multi-Components Preparation on Lipid Biochemistry in ApoE*3Leiden.CETP Mice
H Wei, C Hu, M Wang, AM van Hoek, TH Reijmers, S Wopereis, J Bouwman, R Ramaker, HA Korthout, M Vennik, T Hankemeier, LM Havekes, RF Witkamp, ER Verheij, G Xu, J der Greef, M Federici
PloS one 2012
Effect of 9p21.3 Coronary Artery Disease Locus Neighboring Genes on Atherosclerosis in Mice
JB Kim, A Deluna, IN Mungrue, C Vu, D Pouldar, M Civelek, L Orozco, J Wu, X Wang, S Charugundla, LW Castellani, M Rusek, H Jakubowski, AJ Lusis
Circulation 2012
Low dose of the liver X receptor agonist, AZ876, reduces atherosclerosis in APOE*3Leiden mice without affecting liver or plasma triglyceride levels
J der Hoorn, D Lindén, U Lindahl, M Bekkers, M Voskuilen, R Nilsson, J Oscarsson, E Lindstedt, H Princen
British Journal of Pharmacology 2011
Plasma and liver lipidomics response to an intervention of rimonabant in ApoE*3Leiden.CETP transgenic mice
C Hu, H Wei, AM van Hoek, M Wang, R der Heijden, G Spijksma, TH Reijmers, J Bouwman, S Wopereis, LM Havekes, E Verheij, T Hankemeier, G Xu, J der Greef
PloS one 2011
Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited
J Deelen, M Beekman, HW Uh, Q Helmer, M Kuningas, L Christiansen, D Kremer, R der Breggen, HE Suchiman, N Lakenberg, EB van Akker, WM Passtoors, H Tiemeier, D Heemst, AJ de Craen, F Rivadeneira, EJ de Geus, M Perola, FJ van der Ouderaa, DA Gunn, DI Boomsma, AG Uitterlinden, K Christensen, CM van Duijn, BT Heijmans, JJ Houwing-Duistermaat, RG Westendorp, PE Slagboom
Aging Cell 2011
Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients
FI Staquicini, M Cardó-Vila, MG Kolonin, M Trepel, JK Edwards, DN Nunes, A Sergeeva, E Efstathiou, J Sun, NF Almeida, SM Tu, GH Botz, MJ Wallace, DJ O'Connell, S Krajewski, JE Gershenwald, JJ Molldrem, AL Flamm, E Koivunen, RD Pentz, E Dias-Neto, JC Setubal, DJ Cahill, P Troncoso, KA Do, CJ Logothetis, RL Sidman, R Pasqualini, W Arap
Proceedings of the National Academy of Sciences 2011
Plasma and Liver Lipidomics Response to an Intervention of Rimonabant in ApoE*3Leiden.CETP Transgenic Mice
C Hu, H Wei, AM van Hoek, M Wang, R der Heijden, G Spijksma, TH Reijmers, J Bouwman, S Wopereis, LM Havekes, E Verheij, T Hankemeier, G Xu, J der Greef, M Oresic
PloS one 2011
Microminipig, a Non-rodent Experimental Animal Optimized for Life Science Research: Novel Atherosclerosis Model Induced by High Fat and Cholesterol Diet
H Kawaguchi, N Miyoshi, N Miura, M Fujiki, M Horiuchi, Y Izumi, H Miyajima, R Nagata, K Misumi, T Takeuchi, A Tanimoto, H Yoshida
Journal of Pharmacological Sciences 2011
Endothelial surface layer degradation by chronic hyaluronidase infusion induces proteinuria in apolipoprotein E-deficient mice
MC Meuwese, LN Broekhuizen, M Kuikhoven, S Heeneman, E Lutgens, MJ Gijbels, M Nieuwdorp, CJ Peutz, ES Stroes, H Vink, BM van Berg
PloS one 2010
Ritonavir protects against the development of atherosclerosis in APOE*3-Leiden mice
MA Boer, M Westerterp, JV der Weij, Y Wang, L Hu, SM Santo, T Kooistra, P Reiss, JA Romijn, LM Havekes, PC Rensen
Atherosclerosis 2010
In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor
D Eefting, MR de Vries, JM Grimbergen, JC Karper, JH van Bockel, PH Quax
Journal of Vascular Surgery 2010
A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease
D Eefting, L Seghers, JM Grimbergen, MR de Vries, HC de Boer, JW Lardenoye, JW Jukema, JH van Bockel, PH Quax
Cardiovascular Research 2010
Endothelial Surface Layer Degradation by Chronic Hyaluronidase Infusion Induces Proteinuria in Apolipoprotein E-Deficient Mice
MC Meuwese, LN Broekhuizen, M Kuikhoven, S Heeneman, E Lutgens, MJ Gijbels, M Nieuwdorp, CJ Peutz, ES Stroes, H Vink, BM van Berg, HH Schmidt
PloS one 2010
Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wall
AJ Guri, SA Misyak, R Hontecillas, A Hasty, D Liu, H Si, J Bassaganya-Riera
The Journal of Nutritional Biochemistry 2010
Lipid metabolism in long-lived families: the Leiden Longevity Study.
Vaarhorst AA, Beekman M, Suchiman EH, van Heemst D, Houwing-Duistermaat JJ, Westendorp RG, Slagboom PE, Heijmans BT
Age (Dordrecht, Netherlands) 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Pharmacotherapy of coronary atherosclerosis
AV Finn, MC Kramer, M Vorpahl, FD Kolodgie, R Virmani
Expert Opinion on Pharmacotherapy 2009
The dual PPARα/γ agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice
JW van der Hoorn, JW Jukema, LM Havekes, E Lundholm, G Camejo, PC Rensen, HM Princen
British Journal of Pharmacology 2009
Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program
M Radonjic, JR de Haan, MJ van Erk, KW van Dijk, SA van Berg, PJ de Groot, M Müller, B Ommen
PloS one 2009
Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease
SM Bailey, SK Mantena, T Millender-Swain, Y Cakir, NC Jhala, D Chhieng, KE Pinkerton, SW Ballinger
Free radical biology & medicine 2009
Local lentiviral short hairpin RNA silencing of CCR2 inhibits vein graft thickening in hypercholesterolemic apolipoprotein E3-Leiden mice
D Eefting, I Bot, MR de Vries, A Schepers, JH van Bockel, TJ van Berkel, EA Biessen, PH Quax
Journal of Vascular Surgery 2009
Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol
S Andrade, N Borges
Journal of Dairy Research 2009
Genome-Wide mRNA Expression Analysis of Hepatic Adaptation to High-Fat Diets Reveals Switch from an Inflammatory to Steatotic Transcriptional Program
M Radonjic, JR de Haan, MJ van Erk, KW van Dijk, SA van Berg, PJ de Groot, M Müller, B Ommen, TI Sorensen
PloS one 2009
Animal and cellular models for hypolipidemic drugs
A Cignarella
Expert Opinion on Drug Discovery 2008
Impaired glycocalyx barrier properties contribute to enhanced intimal low-density lipoprotein accumulation at the carotid artery bifurcation in mice
BM Berg, JA Spaan, H Vink
Pflügers Archiv - European Journal of Physiology 2008
Endothelial Cell-Specific NF-κB Inhibition Protects Mice from Atherosclerosis
R Gareus, E Kotsaki, S Xanthoulea, I der Made, MJ Gijbels, R Kardakaris, A Polykratis, G Kollias, MP de Winther, M Pasparakis
Cell Metabolism 2008
Dietary fatty acids affecting hepatic metabolism and atherosclerosis – mechanisms unravelled using a proteomics approach
GR Gutiérrez, BD Roos
Grasas y Aceites 2008
Pathway Analysis for Drug Discovery
A Bugrim, Z Dezso, Y Nikolsky, T Nikolskaya
Pathway Analysis for Drug Discovery 2008
Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE*3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban)
JW van der Hoorn, JW Jukema, ME Bekkers, HM Princen, S Corda, JJ Emeis, P Steendijk
Critical Care Medicine 2008
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice
W Haan, CC van der Hoogt, M Westerterp, M Hoekstra, GM Dallinga-Thie, HM Princen, JA Romijn, JW Jukema, LM Havekes, PC Rensen
Atherosclerosis 2008
Genomics: Fundamentals and Applications
S Jackson, I Patel, J LeClerc, T Cebula, M Mammel, M Kotewicz, A Mukherjee, S Mahata, JR Flores, M Mahata, D O’Connor, J Srinivasan
Genomics: Fundamentals and Applications 2008
Bradykinin- and sodium nitroprusside-induced increases in capillary tube haematocrit in mouse cremaster muscle are associated with impaired glycocalyx barrier properties: Modulation of capillary glycocalyx exclusion by vasodilators
JW VanTeeffelen, AA Constantinescu, J Brands, JA Spaan, H Vink
The Journal of Physiology 2008
Impaired glycocalyx barrier properties contribute to enhanced intimal low-density lipoprotein accumulation at the carotid artery bifurcation in mice
BM van den Berg, JA Spaan, H Vink
Pflügers Archiv - European Journal of Physiology 2008
Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis
R Kleemann, L Verschuren, MJ van Erk, Y Nikolsky, NH Cnubben, ER Verheij, AK Smilde, HF Hendriks, S Zadelaar, GJ Smith, V Kaznacheev, T Nikolskaya, A Melnikov, E Hurt-Camejo, J der Greef, B Ommen, T Kooistra
Genome biology 2007
Does coffee raise cholesterol?
ML Ricketts
Future Lipidology 2007
Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice
JW van der Hoorn, R Kleemann, LM Havekes, T Kooistra, HM Princen, JW Jukema
Journal of Hypertension 2007
Liver X Receptor Alpha Associates With Human Life Span
SP Mooijaart, M Kuningas, RG Westendorp, JJ Houwing-Duistermaat, PE Slagboom, PC Rensen, D Heemst
The Journals of Gerontology Series A Biological Sciences and Medical Sciences 2007
Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression
CC van der Hoogt, W Haan, M Westerterp, M Hoekstra, GM Dallinga-Thie, JA Romijn, HM Princen, JW Jukema, LM Havekes, PC Rensen
Journal of lipid research 2007
ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
SP Mooijaart, JF Berbée, D Heemst, LM Havekes, AJ de Craen, PE Slagboom, PC Rensen, RG Westendorp
PLoS Medicine 2006
Increased atherosclerotic lesion area in apoE deficient mice overexpressing bovine growth hormone
IJ Andersson, A Ljungberg, L Svensson, LM Gan, J Oscarsson, G Bergström
Atherosclerosis 2006
Anti-Atherosclerotic Effect of Amlodipine, Alone and in Combination With Atorvastatin, in APOE*3-Leiden/hCRP Transgenic Mice
A Trion, M Maat, W Jukema, A Maas, E Offerman, L Havekes, A Szalai, A der Laarse, H Princen, J Emeis
Journal of Cardiovascular Pharmacology 2006
Vascular Medicine
ES Klings, J Loscalzo
Vascular Medicine 2006
The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice
D Eefting, A Schepers, MR de Vries, NM Pires, JM Grimbergen, T Lagerweij, LM Nagelkerken, PS Monraats, JW Jukema, JH van Bockel, PH Quax
Atherosclerosis 2006
Plant sterol or stanol esters retard lesion formation in LDL receptor-deficient mice independent of changes in serum plant sterols
J Plat, I Beugels, MJ Gijbels, MP de Winther, RP Mensink
Journal of lipid research 2006
Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice
I Duivenvoorden, PJ Voshol, PC Rensen, W van Duyvenvoorde, JA Romijn, JJ Emeis, LM Havekes, WF Nieuwenhuizen
The American journal of clinical nutrition 2006
Loss of scavenger receptor mediated lipid uptake via SR-A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
Kathryn J. Moore, Vidya V. Kunjathoor, Stephanie L. Koehn, Jennifer J. Manning, Anita A. Tseng, Jessica M. Silver, Mary McKee and Mason W. Freeman
Journal of Clinical Investigation 2005
Reduced Macrophage Apoptosis Is Associated With Accelerated Atherosclerosis in Low-Density Lipoprotein Receptor-Null Mice
J Liu, DP Thewke, YR Su, MR Linton, S Fazio, MS Sinensky
Arteriosclerosis, thrombosis, and vascular biology 2005
Understanding hyperlipidemia and atherosclerosis: lessons from genetically modifiedapoeandldlrmice
K Wouters, R Shiri-Sverdlov, PJ van Gorp, M Bilsen, MH Hofker
Clinical Chemistry and Laboratory Medicine 2005
Genomic analysis of the response of mouse models to high-fat feeding shows a major role of nuclear receptors in the simultaneous regulation of lipid and inflammatory genes
AJ Kreeft, CJ Moen, G Porter, S Kasanmoentalib, R Sverdlov, PJ van Gorp, LM Havekes, RR Frants, MH Hofker
Atherosclerosis 2005
Rosuvastatin Reduces Plasma Lipids by Inhibiting VLDL Production and Enhancing Hepatobiliary Lipid Excretion in ApoE*3-Leiden Mice
DJ Delsing, SM Post, M Groenendijk, K Solaas, H der Boom, W Duyvenvoorde, EC de Wit, VW Bloks, F Kuipers, LM Havekes, HM Princen
Journal of Cardiovascular Pharmacology 2005
Acute inhibition of hepatic β-oxidation in APOE*3Leiden mice does not affect hepatic VLDL secretion or insulin sensitivity
I Duivenvoorden, B Teusink, PC Rensen, F Kuipers, JA Romijn, LM Havekes, PJ Voshol
Journal of lipid research 2005
Hypercholesterolemia impairs reactive hyperemic vasodilation of 2A but not 3A arterioles in mouse cremaster muscle
JW VanTeeffelen, AA Constantinescu, H Vink, JA Spaan
American journal of physiology. Heart and circulatory physiology 2005
LDL receptor cooperates with LDL receptor–related protein in regulating plasma levels of coagulation factor VIII in vivo
N Bovenschen, K Mertens, L Hu, LM Havekes, BJ van Vlijmen
Blood 2005
Response of apolipoprotein E*3‐Leiden transgenic mice to dietary fatty acids: combining liver proteomics with physiological data
B de Roos, I Duivenvoorden, G Rucklidge, M Reid, K Ross, RJ Lamers, PJ Voshol, LM Havekes, B Teusink
The FASEB Journal 2005
Hepatic low-density lipoprotein receptor–related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol
SM Santo, NM Pires, LS Boesten, G Gerritsen, N Bovenschen, KW van Dijk, JW Jukema, HM Princen, A Bensadoun, WP Li, J Herz, LM Havekes, BJ van Vlijmen
Blood 2004
Phenotype Characterisation Using Integrated Gene Transcript, Protein and Metabolite Profiling
M Ore??i??, CB Clish, EJ Davidov, E Verheij, J Vogels, LM Havekes, E Neumann, A Adourian, S Naylor, J der Greef, T Plasterer
Applied Bioinformatics 2004
Methods for the Differential Integrative Omic Analysis of Plasma from a Transgenic Disease Animal Model
E Davidov, CB Clish, M Oresic, M Meys, W Stochaj, P Snell, G Lavine, TR Londo, A Adourian, X Zhang, M Johnston, N Morel, EW Marple, TN Plasterer, E Neumann, E Verheij, JT Vogels, LM Havekes, JV der Greef, S Naylor
OMICS: A Journal of Integrative Biology 2004
A practical approach to using mice in atherosclerosis research
SC Whitman
The Clinical biochemist. Reviews / Australian Association of Clinical Biochemists 2004
Absence of an atheroprotective effect of the garlic powder printanor in APOE*3-Leiden transgenic mice
SM Santo, BJ van Vlijmen, W Duyvenvoorde, EH Offerman, LM Havekes, I Arnault, J Auger, HM Princen
Atherosclerosis 2004
Chylomicron remnant uptake in the livers of mice expressing human apolipoproteins E3, E2 (Arg158→Cys), and E3-Leiden
SJ Lee, I Grosskopf, SY Choi, AD Cooper
Journal of lipid research 2004
Well-Characterized Garlic-Derived Materials Are Not Hypolipidemic in APOE*3-Leiden Transgenic Mice
SM Santo, BJ van Vlijmen, R Buytenhek, W van Duyvenvoorde, LM Havekes, I Arnault, J Auger, HM Princen
The Journal of nutrition 2004
Inhibition of NF-kappaB activation in macrophages promotes atherosclerosis in low-density lipoprotein receptor deficient mice
Edwin Kanters, Manolis Pasparakis, Marion J.J. Gijbels, Monique N. Vergouwe, Iris Partouns-Hendriks, Remond J.A. Fijneman, Björn E. Clausen, Irmgard Förster, Mark M. Kockx, Klaus Rajewsky, Georg Kraal, Marten H. Hofker, Menno P.J. de Winther
Journal of Clinical Investigation 2003
Differential Effects of Amlodipine and Atorvastatin Treatment and Their Combination on Atherosclerosis in ApoE*3-Leiden Transgenic Mice
DJ Delsing, WJ Jukema, MA van de Wiel, JJ Emeis, A der Laarse, LM Havekes, HM Princen
Journal of Cardiovascular Pharmacology 2003
Lung Biology in Health and Disease
N Zamel
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential 2003
Evaluation of antiatherosclerotic drugs by Raman spectroscopy
SW de Poll, A der Laarse
Netherlands Heart Journal 2003
A Fish Oil Diet Does Not Reverse Insulin Resistance despite Decreased Adipose Tissue TNF-α Protein Concentration in ApoE-3*Leiden Mice
M Muurling, RP Mensink, H Pijl, JA Romijn, LM Havekes, PJ Voshol
The Journal of nutrition 2003
Cardiac Ankyrin Repeat Protein (CARP) Expression in Human and Murine Atherosclerotic Lesions: Activin Induces Carp in Smooth Muscle Cells
V de Waard, TA van Achterberg, NJ Beauchamp, H Pannekoek, CJ de Vries
Arteriosclerosis, thrombosis, and vascular biology 2003
Mouse Models of Atherosclerosis
A Daugherty
The American Journal of the Medical Sciences 2002
Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice
SW van de Poll, DJ Delsing, JW Jukema, HM Princen, LM Havekes, GJ Puppels, A der Laarse
Atherosclerosis 2002
Generation and Characterization of Two Transgenic Mouse Lines Expressing Human ApoE2 in Neurons and Glial Cells
S Georgopoulos, A McKee, HY Kan, VI Zannis
Biochemistry 2002
Evaluation of the Role of Lipoprotein Metabolism Genes in Systemic Cationic Liposome-Mediated Gene TransferIn Vivo
LC Mounkes, W Zhong, HV de Silva, C Handumrongkul, B Desai, E Tse, JM Taylor, RJ Debs
Human Gene Therapy 2001
Dietary vegetable oil and wood derived plant stanol esters reduce atherosclerotic lesion size and severity in apoE3-Leiden transgenic mice
OL Volger, RP Mensink, J Plat, G Hornstra, LM Havekes, HM Princen
Atherosclerosis 2001
Dietary Plant Stanol Esters Reduce VLDL Cholesterol Secretion and Bile Saturation in Apolipoprotein E*3-Leiden Transgenic Mice
OL Volger, H van der Boom, EC de Wit, W van Duyvenvoorde, G Hornstra, J Plat, LM Havekes, RP Mensink, HM Princen
Arteriosclerosis, thrombosis, and vascular biology 2001
Mice Expressing Only the Mutant APOE3Leiden Gene Show Impaired VLDL Secretion
AR Mensenkamp, B Teusink, JF Baller, H Wolters, R Havinga, KW van Dijk, LM Havekes, F Kuipers
Arteriosclerosis, thrombosis, and vascular biology 2001
Acyl-CoA:Cholesterol Acyltransferase Inhibitor Avasimibe Reduces Atherosclerosis in Addition to Its Cholesterol-Lowering Effect in ApoE*3-Leiden Mice
DJ Delsing, EH Offerman, W van Duyvenvoorde, H van der Boom, EC de Wit, MJ Gijbels, A van der Laarse, JW Jukema, LM Havekes, HM Princen
Circulation 2001
Compensatory Enlargement and Stenosis Develop in ApoE −/− and ApoE*3-Leiden Transgenic Mice
E Lutgens, ED de Muinck, S Heeneman, MJ Daemen
Arteriosclerosis, thrombosis, and vascular biology 2001
Macrophage p53 Deficiency Leads to Enhanced Atherosclerosis in APOE*3-Leiden Transgenic Mice
BJ van Vlijmen, G Gerritsen, AL Franken, LS Boesten, MM Kockx, MJ Gijbels, MP Vierboom, M van Eck, B van de Water, TJ van Berkel, LM Havekes
Circulation research 2001
Analysis of the structure and function relationship of human apolipoprotein E in vivo, using adenovirus‐mediated gene transfer
KE Kypreos, B Teusink, KO Dijk, LM Havekes, VI Zannis
The FASEB Journal 2001
APOLIPOPROTEINE: Far More Than a Lipid Transport Protein
RW Mahley, SC Rall
Annual Review of Genomics and Human Genetics 2000
The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit
M Kliffen, E Lutgens, MJ Daemen, ED de Muinck, CM Mooy, PT de Jong
The British journal of ophthalmology 2000
Phenotyping apolipoprotein E*3-Leiden transgenic mice by two-dimensional polyacrylamide gel electrophoresis and mass spectrometric identification
JM Skehel, K Schneider, N Murphy, A Graham, GM Benson, P Cutler, P Camilleri
Electrophoresis 2000
A POLIPOPROTEIN E: Far More Than a Lipid Transport Protein
RW Mahley, SC Rall
Annual Review of Genomics and Human Genetics 2000
Macrophage scavenger receptor class A: A multifunctional receptor in atherosclerosis
MP de Winther, KW van Dijk, LM Havekes, MH Hofker
Arteriosclerosis, thrombosis, and vascular biology 2000
Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice
A R Mensenkamp, M J van Luyn, H van Goor, V Bloks, F Apostel, J Greeve, M H Hofker, M C Jong, B J van Vlijmen, L M Havekes, F Kuipers
Journal of Hepatology 2000
Effect of Macrophage-Derived Mouse ApoE, Human ApoE3-Leiden, and Human ApoE2 (Arg158→Cys) on Cholesterol Levels and Atherosclerosis in ApoE-Deficient Mice
MV Eck, N Herijgers, KW Dijk, LM Havekes, MH Hofker, PH Groot, TJ Berkel
Arteriosclerosis, thrombosis, and vascular biology 2000
Accelerated Atherosclerosis by Placement of a Perivascular Cuff and a Cholesterol-Rich Diet in ApoE*3Leiden Transgenic Mice
JH Lardenoye, DJ Delsing, MR de Vries, MM Deckers, HM Princen, LM Havekes, VW van Hinsbergh, JH van Bockel, PH Quax
Circulation research 2000
Cafestol Increases Serum Cholesterol Levels in Apolipoprotein E*3-Leiden Transgenic Mice by Suppression of Bile Acid Synthesis
SM Post, B de Roos, M Vermeulen, L Afman, MC Jong, VE Dahlmans, LM Havekes, F Stellaard, MB Katan, HM Princen
Arteriosclerosis, thrombosis, and vascular biology 2000
Apolipoprotein E and atherosclerosis: insight from animal and human studies
J Davignon, JS Cohn, L Mabile, L Bernier
Clinica Chimica Acta 1999
Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice
MP de Winther, MJ Gijbels, KW van Dijk, PJ van Gorp, H Suzuki, T Kodama, RR Frants, LM Havekes, MH Hofker
Atherosclerosis 1999
Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study
MJ Gijbels, M der Cammen, LJ van der Laan, JJ Emeis, LM Havekes, MH Hofker, G Kraal
Atherosclerosis 1999
Acyl-coenzyme A: Cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7?-hydroxylase in cultured rat hepatocytes andin vivo in the rat
SM Post, JP Zoeteweij, MH Bos, EC de Wit, R Havinga, F Kuipers, HM Princen
Hepatology 1999
Atherosclerosis in APOE*3-Leiden Transgenic Mice: From Proliferative to Atheromatous Stage
E Lutgens, M Daemen, M Kockx, P Doevendans, M Hofker, L Havekes, H Wellens, ED de Muinck
Circulation 1999
Pathogenesis of type III hyperlipoproteinemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes
RW Mahley, Y Huang, SC Rall
Journal of lipid research 1999
Dissection of the complex role of apolipoprotein E in lipoprotein metabolism and atherosclerosis using mouse models
KW van Dijk, MH Hofker, LM Havekes
Current Atherosclerosis Reports 1999
Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis
MH Hofker, BJ van Vlijmen, LM Havekes
Atherosclerosis 1998
LIPOPROTEINS AND ATHEROGENESIS
JM Hoeg
Endocrinology & Metabolism Clinics of North America 1998
Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice
P Leppänen, JS Luoma, MH Hofker, LM Havekes, S Ylä-Herttuala
Atherosclerosis 1998
Trends in Molecular Medicine: Molecular determinants of arterial calcification
T Schinke, MD McKee, R Kiviranta, G Karsenty
Annals of Medicine 1998
Lack of predictability of classical animal models for hypolipidemic activity: a good time for mice?
BR Krause, HM Princen
Atherosclerosis 1998
Dietary cholesterol-induced xanthomatosis in atherosclerosis-susceptible Japanese quail (Cotunix japonica)
KA Hoekstra, CR Nichols, ME Garnett, DV Godin, KM Cheng
Journal of Comparative Pathology 1998
Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice
BJ van Vlijmen, RP Mensink, , RF Offermans, MH Hofker, LM Havekes
Journal of lipid research 1998
Atherosclerosis and the Mouse: A Decade of Experience
A Plump
Annals of Medicine 1997
Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner
MC Jong, VE Dahlmans, MH Hofker, LM Havekes
Biochemical Journal 1997
Use of transgenic mice in lipoprotein metabolism and atherosclerosis research
LM Havekes, BJ Vlijmen, MC Jong, KW Dijk, MH Hofker
Prostaglandins, Leukotrienes and Essential Fatty Acids 1997
Apolipoprotein E2 Transgenic Rabbits: MODULATION OF THE TYPE III HYPERLIPOPROTEINEMIC PHENOTYPE BY ESTROGEN AND OCCURRENCE OF SPONTANEOUS ATHEROSCLEROSIS
Y Huang, SW Schwendner, SC Rall, DA Sanan, RW Mahley
The Journal of biological chemistry 1997
Diagnostics of Vascular Diseases
P Lanzer, M Lipton
1997
Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice
BJ van Vlijmen, HB van Hof, MJ Mol, H der Boom, A der Zee, RR Frants, MH Hofker, LM Havekes
Journal of Clinical Investigation 1996
In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway
MC Jong, VE Dahlmans, PJ van Gorp, KW van Dijk, ML Breuer, MH Hofker, LM Havekes
Journal of Clinical Investigation 1996
Triglycerides: a risk factor for coronary heart disease
J Davignon, JS Cohn
Atherosclerosis 1996
Hypolipidemic and Hyperlipidemic Phenotypes in Transgenic Mice Expressing Human Apolipoprotein E2
Y Huang, SW Schwendner, SC Rall, RW Mahley
The Journal of biological chemistry 1996
In the Absence of Endogenous Mouse Apolipoprotein E, Apolipoprotein E*2(Arg-158 → Cys) Transgenic Mice Develop More Severe Hyperlipoproteinemia than Apolipoprotein E*3-Leiden Transgenic Mice
BJ van Vlijmen, KW van Dijk, HB Hof, PJ van Gorp, A der Zee, H der Boom, ML Breuer, MH Hofker, LM Havekes
The Journal of biological chemistry 1996
Plasma Concentration of Apolipoprotein E in Intermediate-Sized Remnant-Like Lipoproteins in Normolipidemic and Hyperlipidemic Subjects
JS Cohn, M Tremblay, M Amiot, D Bouthillier, M Roy, J Genest, J Davignon
Arteriosclerosis, thrombosis, and vascular biology 1996
Both Lipolysis and Hepatic Uptake of VLDL Are Impaired in Transgenic Mice Coexpressing Human Apolipoprotein E*3Leiden and Human Apolipoprotein C1
MC Jong, VE Dahlmans, PJ van Gorp, ML Breuer, MJ Mol, A van der Zee, RR Frants, MH Hofker, LM Havekes
Arteriosclerosis, thrombosis, and vascular biology 1996
Quantitative Assessment of Aortic Atherosclerosis in APOE*3 Leiden Transgenic Mice and Its Relationship to Serum Cholesterol Exposure
PH Groot, BJ van Vlijmen, GM Benson, MH Hofker, R Schiffelers, M Vidgeon-Hart, LM Havekes
Arteriosclerosis, thrombosis, and vascular biology 1996
Drugs Affecting Lipid Metabolism
AM Gotto, R Paoletti, LC Smith, AL Catapano, AS Jackson
1996
Mouse Models of Atherosclerosis
JL Breslow
Science 1996
Increased response to cholesterol feeding in apolipoprotein C1-deficient mice
JH van Ree, MH Hofker, WJ van Broek, JM van Deursen, H der Boom, RR Frants, B Wieringa, LM Havekes
Biochemical Journal 1995
Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding
J Vanree, M Gijbels, W Vandenbroek, M Hofker, L Havekes
Atherosclerosis 1995
Targeted Inactivation of the Mouse α 2 -Macroglobulin Gene
L Umans, L Serneels, L Overbergh, K Lorent, FV Leuven, HV Berghe
The Journal of biological chemistry 1995
Relative Contributions of Apolipoprotein(a) and Apolipoprotein-B to the Development of Fatty Lesions in the Proximal Aorta of Mice
FP Mancini, DL Newland, V Mooser, J Murata, S Marcovina, SG Young, RE Hammer, DA Sanan, HH Hobbs
Arteriosclerosis, thrombosis, and vascular biology 1995
Cardiovascular Disease 2
LL Gallo
1995
Triglyceride-rich lipoproteins of subjects heterozygous for apolipoprotein E2(Lysl46→Gln) are inefficiently converted to cholesterol-rich lipoproteins
M Mulder, H der Boom, P Kniff, C Braam, A Maagdenberg, JA Leuven, LM Havekes
Atherosclerosis 1994
Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice
JH van Ree, WJ van Broek, VE Dahlmans, PH Groot, M Vidgeon-Hart, RR Frants, B Wieringa, LM Havekes, MH Hofker
Atherosclerosis 1994
Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142)
S Fazio, DA Sanan, YL Lee, ZS Ji, RW Mahley, SC Rall
Arteriosclerosis Thrombosis and Vascular Biology 1994
Animal models of atherosclerosis
ML Armstrong, DD Heistad
Atherosclerosis 1990

← Previous 1 2 3 … 8 9 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts